Anti‐D administration in pregnancy vs no treatment
- Anti‐D administration in pregnancy for preventing Rhesus alloimmunisation 2015 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Anti‐D administration in pregnancy may leads to lower incidence of positive Kleihauer test (at 32 to 35 weeks' gestation) compared with no treatment (low certainty).
Anti‐D administration in pregnancy may leads to lower incidence of positive Kleihauer test (at birth of a Rh‐positive… compared with no treatment (low certainty).
It is very uncertain whether anti‐D administration in pregnancy changes neonatal jaundice compared with no treatment (very low certainty).
Balanced protein and energy supplementation showed no clear difference in neonatal death compared with control or no intervention (low certainty).
Balanced protein and energy supplementation probably leads to lower small‐for‐gestational age compared with control or no intervention (moderate certainty).
Balanced protein and energy supplementation showed no clear difference in preterm birth compared with control or no intervention (moderate certainty).
The intervention showed no clear difference in stillbirth (low certainty).
The intervention showed no clear difference in neonatal death (low certainty).
The intervention probably leads to higher small‐for‐gestational age (moderate certainty).
The intervention showed no clear difference in preterm birth (low certainty).
Nutritional education showed no clear difference in stillbirth compared with no counselling or education during pregnancy (low certainty).